Oculus Innovative Sciences (OCLS) Starts Presentation at LD Micro Main Event
Oculus Innovative Sciences (NASDAQ: OCLS) designs, produces and markets prescription and over-the-counter products based on its Microcyn platform technology for the dermatology, surgical, advanced tissue, skincare and animal healthcare markets. The company's Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of pathogens that cause disease, including viruses, fungi, spores, and bacteria, such as antibiotic-resistant strains. Oculus' Microcyn has received 14 510(k) clearances for use as a medical device in tissue care management consisting of acute and chronic wounds, and in dermatology applications. For more information, visit the company's website at…







